Similar Articles
1781 Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy
1782 Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma
1783 Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma
1784 Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection
1785 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma
1786 Meta-analysis of Barrett’s esophagus in China
1787 Smoking, alcohol consumption, and the risk of extrahepatic cholangiocarcinoma: A meta-analysis
1788 Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients
1789 Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study
1790 Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA